T-cell Lymphoma Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

PROCLIPI: registry & establishment of a prognostic index for MF and SS
Establishing a registry and prognostic index for mycosis fungoides, the most common type of cutaneous T-cell lymphoma (CTCL), and Szary syndrome, a rare type of CTCL, is important to improve the mana... Author: VJHemOnc Added: 10/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 2, 2018 Category: Cancer & Oncology Source Type: podcasts

CD47-blocking checkpoint inhibitor TTI-621 shows promising results for cutaneous T-cell lymphomas
A novel CD47-blocking checkpoint inhibitor has shown promising interim results in a multicenter Phase I trail for relapsed/refractory mycosis fungoides and Szary syndrome, the most common types of cu... Author: VJHemOnc Added: 10/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 2, 2018 Category: Cancer & Oncology Source Type: podcasts

Pathobiology and clinical management of T-cell lymphoma
From the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2018 meeting held in Nice, France, Francine Foss, MD, of Yale University School of Medicine, New Haven, CT, discusses the pathology and... Author: VJHemOnc Added: 10/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 1, 2018 Category: Cancer & Oncology Source Type: podcasts

Challenges in diagnosing and treating CTCL
With cutaneous T-cell lymphoma (CTCL) being a rare disease with an incredibly high prevalence, Pierluigi Porcu, MD, from Sidney Kimmel Cancer Center, Philadelphia, PA, describes the challenges of CTCL... Author: VJHemOnc Added: 09/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 28, 2018 Category: Cancer & Oncology Source Type: podcasts

Antagomir for cutaneous T-cell lymphoma: promising trial results
In cutaneous T-cell lymphoma (CTCL) miR-155 has been shown to be upregulated. Here, Christiane Querfeld, MD, PhD, of City of Hope, Duarte, CA, discusses an antogomir being developed to target this var... Author: VJHemOnc Added: 01/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 8, 2018 Category: Cancer & Oncology Source Type: podcasts

Immune checkpoint inhibitors for cutaneous T-cell lymphoma
Immune checkpoint inhibitors have now entered the treatment landscape for cutaneous T-cell lymphoma (CTCL). In this interview, Christiane Querfeld, MD, PhD, of City of Hope, Duarte, CA, discusses a Ph... Author: VJHemOnc Added: 01/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 8, 2018 Category: Cancer & Oncology Source Type: podcasts

Combining targeted agents with checkpoint inhibitors in cutaneous T-cell lymphoma
"Both targeted agents, such as brentuximab vedotin, and checkpoint inhibitors, such as pembrolizumab, have shown activity in a subset of patients with cutaneous T-cell lymphoma. Francine Foss, MD... Author: VJHemOnc Added: 11/16/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 16, 2017 Category: Cancer & Oncology Source Type: podcasts

JAMA Dermatology : Cutaneous T-Cell Lymphomas
Interview with Ellen J. Kim, M.D., discussing the JAMA Dermatology Patient Page entitled Cutaneous T-Cell Lymphomas (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - June 14, 2017 Category: General Medicine Authors: The JAMA Network Source Type: podcasts

Cutaneous T-Cell Lymphomas
Interview with Ellen J. Kim, M.D., discussing the JAMA Dermatology Patient Page entitled Cutaneous T-Cell Lymphomas (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - June 14, 2017 Category: General Medicine Authors: The JAMA Network Source Type: podcasts

What are the most promising new approaches and agents for T cell lymphoma?
In this presentation from Lymphoma & Myeloma 2016, Jia Ruan discusses the most promising new approaches and agents for the treatment of T cell lymphoma. Click to Earn CME Credit: <a target='_blank' href='http://bit.ly/2mFK'>http://bit.ly/2mFK...</a>... Author: imedex Added: 04/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 11, 2017 Category: Cancer & Oncology Source Type: podcasts

New Targets in peripheral T cell lymphomas
In this presentation from Lymphoma & Myeloma 2016, Dr. David Weinstock discusses new targets in peripheral T cell lymphomas. Click to Earn CME Credit: <a target='_blank' href='http://bit.ly/2mFKBrY'>http://bit.ly/2mFKBrY...</a> 2016 Imedex, LLC. Author: imedex Added: 03/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 8, 2017 Category: Cancer & Oncology Source Type: podcasts

ASH 2016: Cutaneous T-Cell Lymphoma Treatment News
At the 2016 American Society of Hematology (ASH) meeting in San Diego, Dr. Steven Horwitz of Memorial Sloan Kettering Cancer Center explores new and emerging treatments for cutaneous T-cell lymphoma, ... Author: patientpower Added: 12/13/2016 (Source: Oncology Tube)
Source: Oncology Tube - December 14, 2016 Category: Cancer & Oncology Source Type: podcasts

CAR T-Cell Lymphoma Data
Joshua Brody, MD, PhD, of Mount Sinai Hospital, gives an update on CAR T-Cell Lymphoma data from the 58th ASH Annual Meeting in San Diego, CA. Author: ASHReport Added: 12/09/2016 (Source: Oncology Tube)
Source: Oncology Tube - December 9, 2016 Category: Cancer & Oncology Source Type: podcasts

What is in the future for T-cell lymphoma?
Owen O'Connor, MD, PhD from Columbia University Medical Center, New York, NY discusses the positive trend in the research for treating T-cell lymphoma. The last 5 years have been extraordinary with th... Author: VJHemOnc Added: 07/11/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 11, 2016 Category: Cancer & Oncology Source Type: podcasts